Kamada (Israel) Today
| KMDA Stock | ILA 2,605 14.00 0.53% |
Performance20 of 100
| Odds Of DistressLess than 9
|
Kamada is trading at 2605.00 as of the 18th of January 2025, a 0.53% down since the beginning of the trading day. The stock's open price was 2619.0. Kamada has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. KAMADA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 44.8 M outstanding shares. More on Kamada
Moving together with Kamada Stock
Moving against Kamada Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kamada Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kamada's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kamada or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chief Executive Officer | Amir London |
| Business Concentration | Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Kamada (KMDA) is traded on Tel Aviv Stock Exchange in Israel and employs 355 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 667.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kamada's market, we take the total number of its shares issued and multiply it by Kamada's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kamada operates under Biotechnology sector and is part of Health Care industry. The entity has 44.8 M outstanding shares.
Kamada has accumulated about 104.55 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.23.
Check Kamada Probability Of Bankruptcy
Ownership AllocationKamada maintains a total of 44.8 Million outstanding shares. 30% of Kamada outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kamada Ownership Details
Kamada Risk Profiles
Although Kamada's alpha and beta are two of the key measurements used to evaluate Kamada's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.4 | |||
| Semi Deviation | 0.9653 | |||
| Standard Deviation | 1.88 | |||
| Variance | 3.52 |
Kamada Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kamada without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Kamada Corporate Directors
| Itzhak Krinsky | Director | Profile | |
| Tuvia Shoham | Independent Director | Profile | |
| Abraham Havron | Independent Director | Profile | |
| Shmuel Rubinstein | Director | Profile |
Additional Information and Resources on Investing in Kamada Stock
When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..